PRICE T ROWE ASSOCIATES INC /MD/
Position in ALLO — Allogene Therapeutics, Inc.
CIK 80255
BALTIMORE, MD
Position in ALLO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$13,129,400
+$8,732,694 QoQ
Shares Held
5,380,902
+67.7% QoQ
Ownership
1.56%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALLO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,301,022,166 across 256 Biotechnology names. ALLO ranks #96 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in ALLO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,129,400 | 5,380,902 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,396,706 | 3,209,275 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,560,067 | 3,677,474 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,554,885 | 4,030,872 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,140,765 | 4,206,004 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $9,554,267 | 4,485,572 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $13,548,479 | 4,838,743 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $13,491,962 | 5,790,542 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $18,673,956 | 4,177,619 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,612,424 | 2,371,472 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $7,631,289 | 2,407,347 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $26,497,057 | 5,331,400 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $31,271,701 | 6,330,304 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $37,373,902 | 5,941,797 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $63,799,012 | 5,907,316 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $63,374,606 | 5,559,176 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $38,869,955 | 4,266,735 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $48,512,797 | 3,251,528 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $111,512,068 | 4,338,991 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $92,197,598 | 3,535,184 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $122,023,380 | 3,456,753 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $89,849,175 | 3,559,793 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $134,914,463 | 3,577,684 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $162,321,456 | 3,790,786 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $42,856,140 | 2,204,534 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||